1. Barakat SES, El-Zahabi MA, Radwan MF (2000) Synthesis and hypolipidemic activity of some new dibenz[c, e]azepine derivatives. Saudi Pharm J 8(2–3):110–115
2. Boden WE (2000) High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs high-density lipoprotein intervention trial. Am J Cardiol 86:19L–22L Abstract-MEDLINE
3. Chapman JM, Wyrick SD, Maguire JH, Cocolas GH, Hall IH (1984) Hypolipidemic agents of phthalimide derivatives 6. Effect of aromatic vs. non-aromatic imides. J Pharm Res 6:267–269
4. El-Helby AA, El-Zahabi MA, Radwan MF (2003) Synthesis and anticonvulsant activity of some new N-substituted-1, 8-naphthalimides. Egypt J Biomed Sci 11:13–22
5. El-Zahabi MA, Ibrahim MK, Abdel-Rahman AA, El Zahabi HSA (1998) Synthesis and anticonvulsant activity of some new novel 4,4′-dibromo-dibenz [c, e]-Azepin-5,7-(6H)diones. Egypt J Pharm Sci 39(4–6):475–486